Recall Register

Device recall: The Ebb Complete Tamponade System, model #CTS-1000 and Code #OQY. Intended for use in providing temporary control or…

Class II FDA enforcement event 72018. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Clinical Innovations, LLC is voluntarily recalling the Ebb Complete Tamponade System (CTS-1000) Lot Number 1214-F-403.) to address the potential for a balloon leak which may affect the ability to deliver therapy, when needed.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Clinical Innovations, LLC started this device recall on 5 Jan 2015. The firm address in the FDA record is in Murray, UT. FDA put the recall in Class II. FDA event 72018 has 1 product record. The first FDA enforcement report date is 21 Oct 2015. The record gives the status Terminated, with the termination date 21 Apr 2016.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide to MS, MD, TN, NC, IN, FL, AL, and LA, and to France.

Recalling firm

Clinical Innovations, LLC, Murray, UT.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 72018: product records
Recall numberProductQuantityClassStatusReport date
Z-0123-2016The Ebb Complete Tamponade System, model #CTS-1000 and Code #OQY. Intended for use in providing temporary control or reduction of postpartum uterine bleeding.827 unitsClass IITerminated21 Oct 2015

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2015
1,153
Share of these events in Class II
91%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
8

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 72018. https://recallregister.com/fda/ii/72018/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide to MS, MD, TN, NC, IN, FL, AL, and LA, and to France.
What quantity of product is in FDA event 72018?
The FDA record gives this quantity: 827 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2015 have the same class?
91% of the 1,153 device events that started in 2015 are in Class II.